UPDATE : Monday, September 7, 2020
상단여백
ViroMed confirms VM202’s pain control in animal test
ViroMed said it has confirmed that VM202, an investigational gene therapy b...
by Nam Doo-hyun  |  2018-04-18 11:39
라인
‘Genexine’s pipelines worth more than ￦3 trillion’
Biotech firm Genexine’s major pipelines could be worth more than 3 trillion...
by Nam Doo-hyun  |  2018-04-16 15:48
라인
Obesity drug Saxenda’s sheds ‘1-year effect’ stigma
The government has changed its approval for the efficacy and safety of Saxe...
by Nam Doo-hyun  |  2018-04-11 14:11
라인
CG Bio wins nod for 3D printed artificial cheekbones
CG Bio said it has won a nod from the Ministry of Food and Drug Safety to m...
by Nam Doo-hyun  |  2018-04-10 15:12
라인
Boehringer Ingelheim Korea CEO was forced to resign?
Rumors are circulating in the pharmaceutical industry that Park Ki-hwan, CE...
by Nam Doo-hyun  |  2018-04-06 16:10
라인
Pharmaceutical exports jumped 30% in first two months
South Korea’s exports of pharmaceutical products expanded 30 percent in Jan...
by Nam Doo-hyun  |  2018-04-05 15:09
라인
Invossa’s encouraging trial results presented in US
Invossa, gene therapy for osteoarthritis of the knee, has shown promising r...
by Nam Doo-hyun  |  2018-03-28 15:05
라인
Prescriptions of anticancer drugs surged in January
Prescriptions of anticancer drugs surged in January compared to a year earl...
by Nam Doo-hyun  |  2018-03-27 14:14
라인
Opdivo adds gastric cancer to indications
Bristol-Myers Squibb Korea Pharmaceutical and Ono Pharma Korea said their c...
by Nam Doo-hyun  |  2018-03-27 11:34
라인
Stem cell therapy developers unaffected by Cha Biotech debacle
Shares of biotech firms specializing in stem cell therapies are performing ...
by Nam Doo-hyun  |  2018-03-26 15:58
라인
4 drugmakers’ profits turn to losses
Among KOSDAQ-listed pharmaceutical companies, four firms’ operating profits...
by Nam Doo-hyun  |  2018-03-21 11:38
라인
Foreigners buy SillaJen, Samsung BioLogics, dump Celltrion
Foreign investors net purchased shares of SillaJen and Samsung BioLogics, a...
by Nam Doo-hyun  |  2018-03-20 12:01
라인
‘BMS’ Opdivo to lead cancer immunotherapy market’
Cancer immunotherapy Opdivo has become a new growth engine for Bristol-Myer...
by Nam Doo-hyun  |  2018-03-14 15:16
라인
‘Demand for healthcare cloud service rising’
Cloud service providers that help hospitals manage electronic medical recor...
by Nam Doo-hyun  |  2018-03-12 15:03
라인
‘Me Too’ movement spreads to pharma sector
Amid the nationwide spread of “Me Too” movement, a former employee of Janss...
by Nam Doo-hyun  |  2018-03-08 11:48
라인
Will Invossa face rival cell gene therapy?
The pharmaceutical industry is paying keen attention whether Jointstem, a s...
by Nam Doo-hyun  |  2018-03-07 15:00
라인
‘Order receipt to bolster Samsung BioLogics’ sales’
Samsung BioLogics, which enjoyed more than 50 percent revenue growth in the...
by Nam Doo-hyun  |  2018-03-06 15:58
라인
Researchers find diagnostic biomarker for type 2 diabetes
Korean researchers have found a diagnostic biomarker for type 2 diabetes by...
by Nam Doo-hyun  |  2018-03-05 12:16
라인
Seoul spent ￦2 trillion for new drug development in 7 years
The Korean government has invested a total of 1.96 trillion won ($1.8 billi...
by Nam Doo-hyun  |  2018-03-02 11:59
라인
‘Korea needs genome data standardization'
Korea should standardize genome data to cope with the growing demand for ge...
by Nam Doo-hyun  |  2018-02-28 11:31
-12345678910-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top